Number of the records: 1  

certolizumab pegol

  1. Record numberd000068582
    Date06.06.2025
    TypeM - MESH
    Topical termcertolizumab pegol
    Other termSlovak (Pseudonym) CDP870
    See also(Later heading) faktor nekrotizujúci nádory, alfa
    (Skutočné meno) imunosupresíva
    (Skutočné meno) antireumatiká
    (Skutočné meno) inhibítory faktora nekrotizujúceho nádory
    (Skutočné meno) faktor nekrotizujúci nádory, alfa
    UDCD05.750.741.125D12.644.541.500.650.250D12.776.124.486.485.114.224.060.500D12.776.124.486.485.680.650.250D12.776.124.790.651.114.224.060.500D12.776.124.790.651.680.650.250D12.776.377.715.548.114.224.200.500D12.776.377.715.548.680.650.250
    NoteA polyethylene-glycolated Fab' fragment of TUMOR NECROSIS FACTOR antibody that binds specifically to TNF-ALPHA and neutralises it in a dose-dependent manner. It also inhibits the production of lipopolysaccharide-induced TNF-ALPHA and IL-1 BETA and is used to treat RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
    subject heading

    subject heading

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all